The incidence of insomnia increases with age, as does use of sleeping medications. Prolonged use is common but creates the potential for numerous adverse effects. Benzodiazepines are a particular danger for the elderly. Discontinuation of benzodiazepines, however, also poses physiological and psychological risks. To minimize these pitfalls, Morin et al. (p. 332) combined 10 weeks of supervised drug tapering and cognitive behavior therapy for elderly patients who had already tried numerous times to stop taking benzodiazepines for insomnia. At the end of treatment, 85% of the patients were drug free, compared to 54% of patients receiving only cognitive behavior therapy and 48% of those doing drug tapering only. At 12-month follow-up, the rates were 70%, 42%, and 65%, respectively. Adding cognitive behavior therapy to drug tapering helped alleviate insomnia, and sleep improvements became more noticeable after several months.